• Adalimumab may be a promising agent for the management of COVID-19. • Healing speed of the lungs with adalimumab in COVID-19 is considerable. • Adalimumab could be a fast way to control the over-inflammation of COVID-19.
Successful Management of COVID-19 With Adalimumab in a Post-Coronary Artery Bypass Graft Surgery Patient